Efficacy Assessment of an Active Tau Immunotherapy in Alzheimer’s Disease Patients with Amyloid and Tau Pathology: a Post Hoc Analysis of the “ADAMANT” Randomised, Placebo-Controlled, Double-Blind, Multi-Centre, Phase 2 Clinical Trial
EBIOMEDICINE(2024)
关键词
Tau,Alzheimer’s disease,Immunotherapy,Machine learning,Post-hoc analysis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要